請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42897
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴明詔 | |
dc.contributor.author | Chung-Hsin Tseng | en |
dc.contributor.author | 曾忠信 | zh_TW |
dc.date.accessioned | 2021-06-15T01:27:59Z | - |
dc.date.available | 2010-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-22 | |
dc.identifier.citation | 1. Abrahem, A., and M. Pelchat. 2008. Formation of an RNA polymerase II preinitiation complex on an RNA promoter derived from the hepatitis delta virus RNA genome. Nucleic Acids Res 36:5201-11.
2. Balasubramanyam, K., R. A. Varier, M. Altaf, V. Swaminathan, N. B. Siddappa, U. Ranga, and T. K. Kundu. 2004. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279:51163-71. 3. Bell, P., R. Brazas, D. Ganem, and G. G. Maul. 2000. Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J Virol 74:5329-36. 4. Boddy, M. N., K. Howe, L. D. Etkin, E. Solomon, and P. S. Freemont. 1996. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13:971-82. 5. Boggio, R., and S. Chiocca. 2006. Viruses and sumoylation: recent highlights. Curr Opin Microbiol 9:430-6. 6. Bolden, J. E., M. J. Peart, and R. W. Johnstone. 2006. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769-84. 7. Bonino, F., B. Hoyer, J. W. Shih, M. Rizzetto, R. H. Purcell, and J. L. Gerin. 1984. Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun 43:1000-5. 8. Bossis, G., C. E. Malnou, R. Farras, E. Andermarcher, R. Hipskind, M. Rodriguez, D. Schmidt, S. Muller, I. Jariel-Encontre, and M. Piechaczyk. 2005. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol 25:6964-79. 9. Branch, A. D., B. J. Benenfeld, B. M. Baroudy, F. V. Wells, J. L. Gerin, and H. D. Robertson. 1989. An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science 243:649-52. 10. Branch, A. D., and H. D. Robertson. 1984. A replication cycle for viroids and other small infectious RNA's. Science 223:450-5. 11. Caron, C., E. Col, and S. Khochbin. 2003. The viral control of cellular acetylation signaling. Bioessays 25:58-65. 12. Carter, S., and K. H. Vousden. 2008. p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53. Cell Cycle 7:2519-28. 13. Casey, J. L., and J. L. Gerin. 1995. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol 69:7593-600. 14. Chang, F. L., P. J. Chen, S. J. Tu, C. J. Wang, and D. S. Chen. 1991. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A 88:8490-4. 15. Chang, J., X. Nie, H. E. Chang, Z. Han, and J. Taylor. 2008. Transcription of Hepatitis Delta Virus RNA by RNA Polymerase II. J Virol 82:1118-27. 16. Chang, M. F., S. C. Baker, L. H. Soe, T. Kamahora, J. G. Keck, S. Makino, S. Govindarajan, and M. M. Lai. 1988. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol 62:2403-10. 17. Chao, M., S. Y. Hsieh, and J. Taylor. 1990. Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol 64:5066-9. 18. Chen, P. J., G. Kalpana, J. Goldberg, W. Mason, B. Werner, J. Gerin, and J. Taylor. 1986. Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A 83:8774-8. 19. Chien, C. T., P. L. Bartel, R. Sternglanz, and S. Fields. 1991. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A 88:9578-82. 20. Choi, S. H., K. J. Park, and S. B. Hwang. 2002. Large hepatitis delta antigen is phosphorylated at multiple sites and phosphorylation is associated with protein conformational change. Intervirology 45:142-9. 21. Chou, H. C., T. Y. Hsieh, G. T. Sheu, and M. M. Lai. 1998. Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol 72:3684-90. 22. Cunha, C., J. Monjardino, D. Cheng, S. Krause, and M. Carmo-Fonseca. 1998. Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA 4:680-93. 23. Deng, Z., M. Wan, and G. Sui. 2007. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Mol Cell Biol 27:3780-92. 24. Desterro, J. M., M. S. Rodriguez, and R. T. Hay. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2:233-9. 25. Dezelee, S., A. Sentenac, and P. Fromageot. 1974. Role of deoxyribonucleic acid-ribonucleic acid hybrids in eukaryotes. Synthetic ribo- and deoxyribopolynucleotides as template for yeast ribonucleic acid polymerase B (or II). J Biol Chem 249:5978-83. 26. Everett, R. D. 2001. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20:7266-73. 27. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-6. 28. Filipovska, J., and M. M. Konarska. 2000. Specific HDV RNA-templated transcription by pol II in vitro. RNA 6:41-54. 29. Fu, T. B., and J. Taylor. 1993. The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol 67:6965-72. 30. Gaeta, G. B., T. Stroffolini, M. Chiaramonte, T. Ascione, G. Stornaiuolo, S. Lobello, E. Sagnelli, M. R. Brunetto, and M. Rizzetto. 2000. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 32:824-7. 31. Geiss-Friedlander, R., and F. Melchior. 2007. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8:947-56. 32. Glenn, J. S., J. A. Watson, C. M. Havel, and J. M. White. 1992. Identification of a prenylation site in delta virus large antigen. Science 256:1331-3. 33. Glenn, J. S., and J. M. White. 1991. trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol 65:2357-61. 34. Glozak, M. A., N. Sengupta, X. Zhang, and E. Seto. 2005. Acetylation and deacetylation of non-histone proteins. Gene 363:15-23. 35. Gostissa, M., A. Hengstermann, V. Fogal, P. Sandy, S. E. Schwarz, M. Scheffner, and G. Del Sal. 1999. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18:6462-71. 36. Govindarajan, S., K. P. Chin, A. G. Redeker, and R. L. Peters. 1984. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 86:1417-20. 37. Greco-Stewart, V. S., P. Miron, A. Abrahem, and M. Pelchat. 2007. The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome. Virology 357:68-78. 38. Greco-Stewart, V. S., E. Schissel, and M. Pelchat. 2009. The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. Virology 386:12-5. 39. Gudima, S., S. Y. Wu, C. M. Chiang, G. Moraleda, and J. Taylor. 2000. Origin of hepatitis delta virus mRNA. J Virol 74:7204-10. 40. Guo, D., M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R. H. Podolsky, A. Muir, J. Wang, Z. Dong, T. Brusko, M. Atkinson, P. Pozzilli, A. Zeidler, L. J. Raffel, C. O. Jacob, Y. Park, M. Serrano-Rios, M. T. Larrad, Z. Zhang, H. J. Garchon, J. F. Bach, J. I. Rotter, J. X. She, and C. Y. Wang. 2004. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 36:837-41. 41. Hay, R. T. 2007. SUMO-specific proteases: a twist in the tail. Trends Cell Biol 17:370-6. 42. He, L. F., E. Ford, R. H. Purcell, W. T. London, J. Phillips, and J. L. Gerin. 1989. The size of the hepatitis delta agent. J Med Virol 27:31-3. 43. Heun, P. 2007. SUMOrganization of the nucleus. Curr Opin Cell Biol 19:350-5. 44. Hoege, C., B. Pfander, G. L. Moldovan, G. Pyrowolakis, and S. Jentsch. 2002. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419:135-41. 45. Hoofnagle, J. H. 1989. Type D (delta) hepatitis. Jama 261:1321-5. 46. Hsieh, S. Y., and J. Taylor. 1991. Regulation of polyadenylation of hepatitis delta virus antigenomic RNA. J Virol 65:6438-46. 47. Huang, W. H., C. W. Chen, H. L. Wu, and P. J. Chen. 2006. Post-translational modification of delta antigen of hepatitis D virus. Curr Top Microbiol Immunol 307:91-112. 48. Huang, W. H., Y. S. Chen, and P. J. Chen. 2008. Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication. J Virol 82:692-9. 49. Huang, W. H., R. T. Mai, and Y. H. Lee. 2008. Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication. J Virol 82:7313-24. 50. Huang, W. H., B. Y. Yung, W. J. Syu, and Y. H. Lee. 2001. The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem 276:25166-75. 51. Huang, Z. S., W. H. Su, J. L. Wang, and H. N. Wu. 2003. Selective strand annealing and selective strand exchange promoted by the N-terminal domain of hepatitis delta antigen. J Biol Chem 278:5685-93. 52. Huang, Z. S., and H. N. Wu. 1998. Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides. J Biol Chem 273:26455-61. 53. Jayan, G. C., and J. L. Casey. 2002. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J Virol 76:3819-27. 54. Jayan, G. C., and J. L. Casey. 2002. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J Virol 76:12399-404. 55. Jeng, K. S., A. Daniel, and M. M. Lai. 1996. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol 70:2403-10. 56. Jeng, K. S., P. Y. Su, and M. M. Lai. 1996. Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol 70:4205-9. 57. Johnson, E. S. 2004. Protein modification by SUMO. Annu Rev Biochem 73:355-82. 58. Johnson, T. L., and M. J. Chamberlin. 1994. Complexes of yeast RNA polymerase II and RNA are substrates for TFIIS-induced RNA cleavage. Cell 77:217-24. 59. Kos, A., R. Dijkema, A. C. Arnberg, P. H. van der Meide, and H. Schellekens. 1986. The hepatitis delta (delta) virus possesses a circular RNA. Nature 323:558-60. 60. Kuo, M. Y., M. Chao, and J. Taylor. 1989. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol 63:1945-50. 61. Kuo, M. Y., L. Sharmeen, G. Dinter-Gottlieb, and J. Taylor. 1988. Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol 62:4439-44. 62. Lai, M. M. 2005. RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol 79:7951-8. 63. Lamsoul, I., J. Lodewick, S. Lebrun, R. Brasseur, A. Burny, R. B. Gaynor, and F. Bex. 2005. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol Cell Biol 25:10391-406. 64. Lazinski, D. W., and J. M. Taylor. 1993. Relating structure to function in the hepatitis delta virus antigen. J Virol 67:2672-80. 65. Lee, C. H., S. C. Chang, C. J. Chen, and M. F. Chang. 1998. The nucleolin binding activity of hepatitis delta antigen is associated with nucleolus targeting. J Biol Chem 273:7650-6. 66. Lee, C. Z., P. J. Chen, and D. S. Chen. 1995. Large hepatitis delta antigen in packaging and replication inhibition: role of the carboxyl-terminal 19 amino acids and amino-terminal sequences. J Virol 69:5332-6. 67. Lee, C. Z., J. H. Lin, M. Chao, K. McKnight, and M. M. Lai. 1993. RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol 67:2221-7. 68. Lehmann, E., F. Brueckner, and P. Cramer. 2007. Molecular basis of RNA-dependent RNA polymerase II activity. Nature 450:445-9. 69. Li, Y. J., T. Macnaughton, L. Gao, and M. M. Lai. 2006. RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies. J Virol 80:6478-86. 70. Li, Y. J., M. R. Stallcup, and M. M. Lai. 2004. Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol 78:13325-34. 71. Lin, D. Y., Y. S. Huang, J. C. Jeng, H. Y. Kuo, C. C. Chang, T. T. Chao, C. C. Ho, Y. C. Chen, T. P. Lin, H. I. Fang, C. C. Hung, C. S. Suen, M. J. Hwang, K. S. Chang, G. G. Maul, and H. M. Shih. 2006. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24:341-54. 72. Luo, G. X., M. Chao, S. Y. Hsieh, C. Sureau, K. Nishikura, and J. Taylor. 1990. A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol 64:1021-7. 73. Macnaughton, T. B., E. J. Gowans, S. P. McNamara, and C. J. Burrell. 1991. Hepatitis delta antigen is necessary for access of hepatitis delta virus RNA to the cell transcriptional machinery but is not part of the transcriptional complex. Virology 184:387-90. 74. Macnaughton, T. B., and M. M. Lai. 2002. Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol 76:3928-35. 75. Macnaughton, T. B., and M. M. Lai. 2006. HDV RNA replication: ancient relic or primer? Curr Top Microbiol Immunol 307:25-45. 76. Macnaughton, T. B., and M. M. Lai. 2002. Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established. J Virol 76:9910-9. 77. Macnaughton, T. B., Y. I. Li, A. L. Doughty, and M. M. Lai. 2003. Hepatitis delta virus RNA encoding the large delta antigen cannot sustain replication due to rapid accumulation of mutations associated with RNA editing. J Virol 77:12048-56. 78. Macnaughton, T. B., S. T. Shi, L. E. Modahl, and M. M. Lai. 2002. Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases. J Virol 76:3920-7. 79. Macnaughton, T. B., Y. J. Wang, and M. M. Lai. 1993. Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol 67:2228-34. 80. Mahajan, R., C. Delphin, T. Guan, L. Gerace, and F. Melchior. 1997. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88:97-107. 81. Makino, S., M. F. Chang, C. K. Shieh, T. Kamahora, D. M. Vannier, S. Govindarajan, and M. M. Lai. 1987. Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature 329:343-6. 82. Matunis, M. J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135:1457-70. 83. Melchior, F. 2000. SUMO--nonclassical ubiquitin. Annu Rev Cell Dev Biol 16:591-626. 84. Meulmeester, E., M. Kunze, H. H. Hsiao, H. Urlaub, and F. Melchior. 2008. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol Cell 30:610-9. 85. Meulmeester, E., and F. Melchior. 2008. Cell biology: SUMO. Nature 452:709-11. 86. Modahl, L. E., and M. M. Lai. 2000. The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J Virol 74:7375-80. 87. Modahl, L. E., and M. M. Lai. 1998. Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol 72:5449-56. 88. Modahl, L. E., T. B. Macnaughton, N. Zhu, D. L. Johnson, and M. M. Lai. 2000. RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol 20:6030-9. 89. Monjardino, J. 1996. Replication of hepatitis delta virus. J Viral Hepat 3:163-6. 90. Moraleda, G., and J. Taylor. 2001. Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome. J Virol 75:10161-9. 91. Mu, J. J., D. S. Chen, and P. J. Chen. 2001. The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication. J Virol 75:9087-95. 92. Mu, J. J., Y. G. Tsay, L. J. Juan, T. F. Fu, W. H. Huang, D. S. Chen, and P. J. Chen. 2004. The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis. Virology 319:60-70. 93. Mu, J. J., H. L. Wu, B. L. Chiang, R. P. Chang, D. S. Chen, and P. J. Chen. 1999. Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens. J Virol 73:10540-5. 94. Mukhopadhyay, D., and M. Dasso. 2007. Modification in reverse: the SUMO proteases. Trends Biochem Sci 32:286-95. 95. Muller, S., A. Ledl, and D. Schmidt. 2004. SUMO: a regulator of gene expression and genome integrity. Oncogene 23:1998-2008. 96. Nedialkov, Y. A., X. Q. Gong, S. L. Hovde, Y. Yamaguchi, H. Handa, J. H. Geiger, H. Yan, and Z. F. Burton. 2003. NTP-driven translocation by human RNA polymerase II. J Biol Chem 278:18303-12. 97. Pichler, A., P. Knipscheer, E. Oberhofer, W. J. van Dijk, R. Korner, J. V. Olsen, S. Jentsch, F. Melchior, and T. K. Sixma. 2005. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat Struct Mol Biol 12:264-9. 98. Reid, C. E., and D. W. Lazinski. 2000. A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. Proc Natl Acad Sci U S A 97:424-9. 99. Rizzetto, M. 2009. Hepatitis D: thirty years after. J Hepatol 50:1043-50. 100. Rizzetto, M., M. G. Canese, S. Arico, O. Crivelli, C. Trepo, F. Bonino, and G. Verme. 1977. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18:997-1003. 101. Rizzetto, M., B. Hoyer, M. G. Canese, J. W. Shih, R. H. Purcell, and J. L. Gerin. 1980. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A 77:6124-8. 102. Romero, M. R., T. Efferth, M. A. Serrano, B. Castano, R. I. Macias, O. Briz, and J. J. Marin. 2005. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an 'in vitro' replicative system. Antiviral Res 68:75-83. 103. Ryu, W. S., M. Bayer, and J. Taylor. 1992. Assembly of hepatitis delta virus particles. J Virol 66:2310-5. 104. Ryu, W. S., H. J. Netter, M. Bayer, and J. Taylor. 1993. Ribonucleoprotein complexes of hepatitis delta virus. J Virol 67:3281-7. 105. Sato, S., C. Cornillez-Ty, and D. W. Lazinski. 2004. By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression. J Virol 78:8120-34. 106. Sheu, G. T., and M. M. Lai. 2000. Recombinant hepatitis delta antigen from E. coli promotes hepatitis delta virus RNA replication only from the genomic strand but not the antigenomic strand. Virology 278:578-86. 107. Si, X., Y. Wang, J. Wong, J. Zhang, B. M. McManus, and H. Luo. 2007. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol 81:3142-50. 108. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64:435-59. 109. Sureau, C., B. Guerra, and R. E. Lanford. 1993. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol 67:366-72. 110. Tavanez, J. P., C. Cunha, M. C. Silva, E. David, J. Monjardino, and M. Carmo-Fonseca. 2002. Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm. RNA 8:637-46. 111. Taylor, J. M. 2006. Structure and replication of hepatitis delta virus RNA. Curr Top Microbiol Immunol 307:1-23. 112. Tseng, C. H., K. S. Jeng, and M. M. Lai. 2008. Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis. J Virol 82:9409-16. 113. Wang, C. C., T. C. Chang, C. W. Lin, H. L. Tsui, P. B. Chu, B. S. Chen, Z. S. Huang, and H. N. Wu. 2003. Nucleic acid binding properties of the nucleic acid chaperone domain of hepatitis delta antigen. Nucleic Acids Res 31:6481-92. 114. Wang, K. S., Q. L. Choo, A. J. Weiner, J. H. Ou, R. C. Najarian, R. M. Thayer, G. T. Mullenbach, K. J. Denniston, J. L. Gerin, and M. Houghton. 1986. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 323:508-14. 115. Wilson, V. G., and D. Rangasamy. 2001. Viral interaction with the host cell sumoylation system. Virus Res 81:17-27. 116. Wong, S. K., and D. W. Lazinski. 2002. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A 99:15118-23. 117. Wu, Y. C., A. F. Deyrieux, and V. G. Wilson. 2007. Papillomaviruses and the host SUMOylation system. Biochem Soc Trans 35:1433-5. 118. Xia, Y. P., C. T. Yeh, J. H. Ou, and M. M. Lai. 1992. Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol 66:914-21. 119. Xue, Y., F. Zhou, C. Fu, Y. Xu, and X. Yao. 2006. SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res 34:W254-7. 120. Yamaguchi, Y., J. Filipovska, K. Yano, A. Furuya, N. Inukai, T. Narita, T. Wada, S. Sugimoto, M. M. Konarska, and H. Handa. 2001. Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science 293:124-7. 121. Yamaguchi, Y., T. Mura, S. Chanarat, S. Okamoto, and H. Handa. 2007. Hepatitis delta antigen binds to the clamp of RNA polymerase II and affects transcriptional fidelity. Genes Cells 12:863-75. 122. Yang, C. K., J. H. Kim, D. K. Ann, and M. R. Stallcup. 2008. Differential regulation of the two transcriptional activation domains of the coiled-coil coactivator CoCoA by sumoylation. BMC Mol Biol 9:12. 123. Yang, X. J. 2004. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26:1076-87. 124. Yang, X. J. 2005. Multisite protein modification and intramolecular signaling. Oncogene 24:1653-62. 125. Zhang, C., H. Yan, and Z. F. Burton. 2003. Combinatorial control of human RNA polymerase II (RNAP II) pausing and transcript cleavage by transcription factor IIF, hepatitis delta antigen, and stimulatory factor II. J Biol Chem 278:50101-11. 126. Zhao, J. 2007. Sumoylation regulates diverse biological processes. Cell Mol Life Sci 64:3017-33. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42897 | - |
dc.description.abstract | D 型肝炎病毒利用宿主細胞的核醣核酸聚合酶來執行其核醣核酸基因組之複製。然而截至目前為止,我們尚不清楚其確切的複製機轉。以前的研究報告顯示,小型D 型肝炎病毒蛋白的蛋白質轉譯後修飾於D 型肝炎病毒核酸複製中扮演著重要角色。其中,小型D 型肝炎病毒蛋白的S-177 磷酸化、K-72 乙醯化及R-13 甲基化已被證明會影響病毒基因股核醣核酸的生成而不影響其反基因股核醣核酸的生成。在本篇論文的前半部,我們探討了小型D 型肝炎病毒蛋白的轉譯後修飾對於
D 型肝炎病毒蛋白的訊息核醣核酸生成之影響。我們的研究證明小型D 型肝炎病毒蛋白的S-177 磷酸化、K-72 乙醯化及R-13 甲基化亦會影響病毒蛋白訊息核醣核酸的生成。於本篇論文的後半部,我們探討了小型D 型肝炎病毒蛋白的SUMO 修飾(sumoylation)及其對於D 型肝炎病毒核醣核酸複製之影響。我們證明小型D 型肝炎病毒蛋白可被SUMO1 蛋白所修飾。利用融合蛋白之方式,我們發現小型D型肝炎病毒蛋白與SUMO1 蛋白的融合會增加D 型肝炎病毒基因股核醣核酸及病 毒蛋白訊息核醣核酸的生成,但卻不影響病毒的反基因股核醣核酸的生成。綜合上述,我們的研究結果支持D 型肝炎病毒基因股核醣核酸及病毒蛋白訊息核醣核酸的生成與其反基因股核醣核酸的生成乃由不同的核醣核酸複製機轉所執行之論點。 | zh_TW |
dc.description.abstract | Hepatitis delta virus (HDV) contains a viroid-like, 1.7-kb circular RNA genome, which replicates via a double rolling circle model. However, the exact mechanism involved in HDV genome RNA replication and subgenomic mRNA transcription is still unclear. Previously, it has been shown that post-translational modifications of S-HDAg, such as phosphorylation, acetylation and methylation, can modulate HDV RNA replication. In the first part of this study (see Section 1), we focused on the issue of how these modifications affect the HDV mRNA transcription. Using a unique qRT-PCR procedure and a series of HDV mutants, we demonstrated that Arg-13 methylation, Lys-72 acetylation, and Ser-177 phosphorylation of S-HDAg are required for the HDV mRNA transcription. The results of this part of study have been published in the Journal of Virology (J Virol 2008; 82:9409-9416).
In the second part of this study (see Section 2), we demonstrated that S-HDAg is a small ubiquitin-like modifier-1 (SUMO1) target protein. Mapping data showed that multiple lysine residues are SUMO1 acceptors within S-HDAg. Using a genetic fusion strategy, we found that conjugation of SUMO1 to S-HDAg selectively enhances HDV genomic RNA and mRNA synthesis but not antigenomic RNA synthesis. The results of this part of study have also been submitted for publication (manuscript in revision). Collectively, these results add to the growing list of different metabolic requirements between the HDV genomic RNA/mRNA synthesis and the antigenomic RNA synthesis (see Section 3, Table 3-1, p76) and support the hypothesis that the cellular machinery involved in the synthesis of HDV antigenomic RNA is different from that of genomic RNA synthesis and mRNA transcription (see Section 3, Fig. 3-3, p79). Finally, in Section 3 of this dissertation, the recent advances in the understanding of HDV RNA replication are reviewed. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:27:59Z (GMT). No. of bitstreams: 1 ntu-98-D93445009-1.pdf: 2577592 bytes, checksum: 9cd608c812a9686849b8c43e30a3feee (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 口試委員審定書…1
中文摘要…2 ABSTRACT…3 ABBREVIATION…4 SECTION 1: Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis 1.1 Summary....8 1.2 Introduction…9 1.3 Materials and Methods…11 1.4 Results…13 1.5 Discussion…19 1.6 Tables…24 1.7 Figures…26 SECTION 2: Hepatitis delta virus antigen is a SUMO target, and SUMO1 conjugation regulates RNA replication 2.1 Summary…34 2.2 Introduction…34 2.3 Materials and Methods…36 2.4 Results…39 2.5 Discussion…47 2.6 Figures…50 SECTION 3: Recent advances in the understanding of HDV RNA replication 3.1 Summary…63 3.2 Introduction…63 3.3 Structure of HDV and HDV RNA…64 3.4 HDAg…65 3.5 An overview of the HDV replication cycle…66 3.6 The role of HDAg in HDV RNA replication….67 3.7 Enzymology of HDV RNA replication…71 3.8 Perspectives…74 3.9 Table…76 3.10 Figures…77 REFERENCES…80 | |
dc.language.iso | en | |
dc.title | D型肝炎病毒蛋白之轉譯後修飾對於調節病毒核酸複製之研究 | zh_TW |
dc.title | Study of Post-translational Modification of Delta Antigen in Regulating Hepatitis Delta Virus RNA Replication | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 吳肇卿,陳培哲,林宜玲,施信如 | |
dc.subject.keyword | D型肝炎病,磷酸化,乙醯化,甲基化, | zh_TW |
dc.subject.keyword | Hepatitis delta virus,phosphorylation,acetylation,methylation,sumoylation, | en |
dc.relation.page | 94 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-22 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 2.52 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。